mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.7 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |